Early access
Sign in
CompletedNo phase

Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care

Key facts

Who runs it
Manchester University NHS Foundation Trust
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
1 Nov 2022
Ended
1 May 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Geko device
  • Flowtron DVT
Record updated
25 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Male or female aged ≥ 18 years
  • Intact healthy skin at the proposed site of gekoTM device application
  • Within 24 hours of their admission to critical care
  • Expected to remain in critical care until the day after tomorrow

Who cannot take part

  • Use of any concurrent neuro-modulation drug or device (e.g. neuromuscular blocking agents)
  • Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve
  • Inability to palpate the fibula head in order to apply geko device effectively
  • Inability to obtain valid written consent from the participant or their designated legal representative

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this prospective, randomised, open-label, parallel group, feasibility trial; the investigators will objectively assess whether it is feasible to apply the Geko device to critically ill adults for the prevention of venous thromboembolism (VTE) compared to usual care with intermittent pneumatic compression devices (IPCs).

The 2 groups in the trial

  • Intervention armTreatment being tested

    Application of the Geko device for mechanical VTE prophylaxis up until day 10 / discharge form critical care (whichever comes sooner).

    Treatment: Geko device

  • Usual care armExisting treatment, for comparison

    Application of our usual intermittent pneumatic compression devices for mechanical VTE prophylaxis up until day 10 / discharge form critical care (whichever comes sooner).

    Treatment: Flowtron DVT

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Electronic Neuromuscular Stimulation Versus Intermittent pneumAtic Compression Devices for the pRevention of Venous Thromboembolic Disease in Critically Ill Adults: a Randomised Feasibility Study
Record updated
25 September 2025